Marketscreener, stock market website
6d698753acb9d717ce23a.VBeVFYNEKQ4HFaMfsA010yEY7NpdB8ImT_CpbynKT9k.DX3xb-YvS0xBQfx-4zplmxhpm4I1VPFKfpvkH0KkJLMXJ9FM7jRYOV4llw

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    United Kingdom
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    LVMH
    EON SE
    IBM
    ALPHABET INC.
    ACCELERANT HOLDINGS
    VOLKSWAGEN AG
    SIEMENS AG
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    S&P 500
    NASDAQ 100
    TSX COMP
    SHANGHAI COMPOSITE
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    GBP / USD
    GBP / EUR
    GBP / CHF
    GBP / RUB
    GBP / SEK
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation, and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Sectors
    All our articles
    Most Read News
    Hot News
  • Analysis
    All Articles
    Must Read
    Equities Analysis
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
  • Calendar
    Economic Calendar
    Company calendar
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Quality stocks at a reasonable price
    Monthly dividends
    Growth stocks
    Growth stocks at reasonable prices
    Top ROE
    Undervalued stocks
    Investment Themes
    Homepage
    E-Commerce & Logistics
    3D Printing
    Bionic engineering
    Outdoor
    Quantum computing
    Serial buyers
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    REITS
    Luxury
    Gold and Silver
    The future of mobility
    Smart City
    Biomass
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • United Kingdom
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • LVMH
      • EON SE
      • IBM
      • ALPHABET INC.
      • ACCELERANT HOLDINGS
      • VOLKSWAGEN AG
      • SIEMENS AG
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
      • S&P 500
      • NASDAQ 100
      • TSX COMP
      • SHANGHAI COMPOSITE
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • GBP / USD
      • GBP / EUR
      • GBP / CHF
      • GBP / RUB
      • GBP / SEK
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation, and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Sectors
    • All our articles
    • Most Read News
    • Hot News
  • Analysis
    • All Articles
    • Must Read
    • Equities Analysis
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
  • Calendar
    • Economic Calendar
    • Company calendar
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • European Portfolio
    • USA Portfolio
    • Asian Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Quality stocks at a reasonable price
      • Monthly dividends
      • Growth stocks
      • Growth stocks at reasonable prices
      • Top ROE
      • Undervalued stocks
    • Investment Themes
      • Homepage
      • E-Commerce & Logistics
      • 3D Printing
      • Bionic engineering
      • Outdoor
      • Quantum computing
      • Serial buyers
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • REITS
      • Luxury
      • Gold and Silver
      • The future of mobility
      • Smart City
      • Biomass
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock IQV IQVIA HOLDINGS INC.
Add to a list

Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse
Other stock markets
21:00:02 20/01/2026 GMT
5-day change 1st Jan Change
233.69 USD -1.68% Intraday chart for Iqvia Holdings Inc. -3.26% +3.67%
01-16 Promising launch for Wegovy pill: Novo Nordisk shares surge in the US Zonebourse
01-16 Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly RE
Summary
Quotes
Charts
Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas
Company
Profile Governance Share ownership Group Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Barclays Adjusts PT on IQVIA Holdings to $230 From $200, Maintains Equalweight Rating

Published on 12/15/2025 at 02:53 pm GMT

MT Newswires
Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
mtnewswires logo
© MT Newswires - 2025
Share

Latest news about Iqvia Holdings Inc.

01-16 Promising launch for Wegovy pill: Novo Nordisk shares surge in the US Zonebourse
01-16 Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly RE
01-16 Baird Adjusts Price Target on IQVIA Holdings Inc to $268 From $258, Maintains Outperform Rating MT
01-16 Novo's Wegovy pill tracks 3,071 prescriptions in first days of launch RE
01-15 Pharma sector doubles down on AI amid hopes of slashing costs, timelines RE
01-15 Zydus Lifesciences Limited Receives Final Approval from USFDA for Eltrombopag Tablets, 12.5 mg, 25 mg, 50 mg, and 75 mg CI
01-13 Rothschild & Co Redburn Adjusts IQVIA Price Target to $287 From $254, Maintains Buy Rating MT
01-12 Alembic Pharmaceuticals Limited Receives USFDA Tentative Approval for Bosutinib Tablets, 400 Mg CI
01-09 Mizuho Securities Adjusts IQVIA Holdings Price Target to $266 From $250, Maintains Outperform Rating MT
01-08 Syneos Health, Inc. Appoints Simon Bartle as Chief Human Resources Officer, Effective January 8, 2026 CI
01-08 UBS Adjusts Price Target on IQVIA to $280 From $250, Maintains Buy Rating MT
01-08 Truist Raises Price Target on IQVIA Holdings to $290 From $265, Keeps Buy Rating MT
12-30 M&S launches new food range for customers on weight-loss jabs AN
12-26 Formosa Pharmaceuticals, Inc. Receives Screening Acceptance Letter from SAHPRA for the Registration of App13007 CI
12-22 Granules India Arm Gets US FDA's Tentative Nod for Generic Amphetamine Extended-Release Tablets MT
12-19 Deutsche Bank Adjusts Price Target on IQVIA Holdings to $250 From $235, Maintains Buy Rating MT
12-18 Stifel Nicolaus Adjusts IQVIA Price Target to $273 From $254, Maintains Buy Rating MT
12-18 Alembic Pharmaceuticals Limited Announces USFDA Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution CI
12-17 Bavarian Nordic as Appoints Anne Louise Eberhard as New Chair of the Board of Directors CI
12-15 Barclays Adjusts PT on IQVIA Holdings to $230 From $200, Maintains Equalweight Rating MT
12-11 Glenmark Pharmaceuticals to Launch Leucovorin Calcium for Injection MT
12-10 Scienture and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli, the First FDA-Approved Ready-To-Use Oral Suspension of Losartan Potassium CI
12-09 IQVIA Holdings Inc. Enter into an Amendment to Its Fifth Amended and Restated Credit Agreement CI
12-08 Halozyme Therapeutics, Inc. Announces Election of Jim Lang to Board of Directors, Effective December 4, 2025 CI
12-02 Amneal Pharmaceuticals, Inc. Receives U.S. Fda Approval for Albuterol Sulfate Inhalation Aerosol CI

Chart Iqvia Holdings Inc.

Chart Iqvia Holdings Inc.
IQV: Dynamic Chart

Company Profile

Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).
Employees
91,000
Sector
Biotechnology & Medical Research
Calendar
02-05 - Q4 2025 Earnings Release
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI
AAA
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
233.69USD
Average target price
259.65USD
Spread / Average Target
+11.11%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Currencies & Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies

Interest Rates

Interest Rates Area
  1. Stock Market
  2. Stock Market News
  3. Barclays Adjusts PT on IQVIA Holdings to $230 From $200, Maintains Equalweight Rating
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,300,000members

+ 1,300,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
The best tools reserved for subscribers to boost the performance of your investments!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong